# Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response

> **NCT04414761** · PHASE3 · COMPLETED · sponsor: **ShangHai Ji Ai Genetics & IVF Institute** · enrollment: 784 (actual)

## Conditions studied

- IVF
- GnRH Antagonist
- PPOS

## Interventions

- **DRUG:** Progesterone
- **DRUG:** GnRH Antagonist

## Key facts

- **NCT ID:** NCT04414761
- **Lead sponsor:** ShangHai Ji Ai Genetics & IVF Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-04
- **Primary completion:** 2022-10-10
- **Final completion:** 2022-10-10
- **Target enrollment:** 784 (ACTUAL)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04414761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04414761, "Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04414761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*